The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials

被引:0
作者
Kiameesha R. Evans
M. Jane Lewis
Shawna V. Hudson
机构
[1] UMDNJ–School of Public Health,Department of Health Education and Behavioral Science
[2] UMDNJ-Robert Wood Johnson Medical School,The Cancer Institute of New Jersey
[3] UMDNJ-Robert Wood Johnson Medical School,Department of Family Medicine and Community Health
来源
Journal of Cancer Education | 2012年 / 27卷
关键词
Clinical trials; Cancer; African Americans; Hispanics/Latinos; Health literacy; Focus group;
D O I
暂无
中图分类号
学科分类号
摘要
Although cancer clinical trials are important for discovering lifesaving therapies, participation remains low among racial/ethnic minorities, and little research explores the role of health literacy in racial/ethnic minority perceptions of cancer clinical trials (CCTs). Five focus groups (n = 50) with African American and Hispanic participants explored CCT perceptions using a multidimensional health literacy framework. We found poor scientific literacy including misconceptions of scientific information, perceptions of clinical trials as uncertain and fear; limited civic literacy around topics of trust, perceptions of participants as guinea pigs, and concerns about of IRB protections; and cultural literacy challenges regarding the importance of home remedies for health, use of native language, and the importance of race/ethnicity matching to health care professionals. Results highlight the importance of attending to scientific literacy, cultural literacy, and civic literacy. Future educational interventions regarding cancer clinical trials should address the importance of health literacy in understanding cancer clinical trial decision making.
引用
收藏
页码:299 / 305
页数:6
相关论文
共 70 条
[1]  
Siegel R(2011)Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 212-236
[2]  
Ward E(2003)Prevention and early detection clinical trials: opportunities for primary care providers and their patients CA Cancer J Clin 53 82-101
[3]  
Brawley O(2008)Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all Ann Surg Oncol 15 1818-1819
[4]  
Jemal A(2004)Participation in cancer clinical trials: race-, sex-, and age-based disparities JAMA 291 2720-2726
[5]  
Ford LG(2010)Adapting a program to inform African American and Hispanic women about cancer clinical trials J Canc Educ 25 142-145
[6]  
Minasian LM(2003)Women’s feedback on chemopreventive trial for cervical dysplasia App Nurs Res 16 22-28
[7]  
McCaskill-Stevens W(1999)Attitudes and beliefs of African Americans toward participation in medical research J Gen Intern Med 14 537-546
[8]  
Pisano ED(2006)Identifying motivations and barriers to patient participation in clinical trials J Canc Educ 21 237-242
[9]  
Sullivan D(2004)Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision J Clin Oncol 22 4312-4318
[10]  
Smith RA(2005)Understanding health literacy: an expanded model Health Promot Int 20 195-203